We provide professional support in Nuclear Medicine.
In our Nuclear Medicine clinic at Yeditepe University Hospital, we offer a full range of PET/CT and
Radio immunotherapy (RAI) services.
Radiopharmaceuticals are used in the field
of nuclear medicine as tracers in medical imaging and
in therapy for many diseases (for
example, brachytherapy). The
radioactive isotope samarium-153 is the major component of the
drug samarium (153Sm) lexidronam (Quadramet), which kills cancer cells in
the treatment of lung cancer, prostate cancer, breast
cancer and osteosarcoma.
PET/CT is a monitoring machine, which is the combination
of PET (Positron Emission Tomography) and CT (computerised tomography). While
PET gives information about the functions and metabolisms of cells, CT provides
anatomic data about size, location and density.
Studies show that PET/CT is highly beneficial in
determining the extent of disease, deciding the type of treatment and observing
suspicious situations like relapses. It plays an important role in determining
the treatment to be used during staging (surgery, surgery
chemotherapy/radiotherapy, chemotherapy/radiotherapy etc.). It is also possible
to have more accurate staging by determining whether indications such as bones
imaged with other diagnostic approaches, liver lesions, lymph nodes and lymph
nodes, are related to the tumor.
Thus patients are saved from unnecessary surgical interventions and correct staging can render
previously inoperable patients candidates for surgery.
Relapses can be determined earlier.
Since the extent of the disease can be determined better, unnecessary treatments can be avoided and
more suitable treatment methods can be used.
With evaluation of the likely response to treatment, the decision to continue chemotherapy or if
necessary to change chemotherapy drugs can be done in earlier stages.